Leptin and the proinflammatory state associated with human obesity

C.J. Hukshorn, J.H. Lindeman*, K.H. Toet, W.H. Saris, P.H. Eilers, M.S. Plantenga, T. Kooistra

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

170 Downloads (Pure)

Abstract

It has been suggested that elevated leptin levels underlie the low grade proinflammatory state in human obesity. We reasoned that if elevated leptin levels are an important factor in the proinflammatory state in obesity, then exogenous leptin administration during weight loss should counteract the concurrent beneficial effects of weight loss on the proinflammatory state. We therefore determined whether long-acting pegylated recombinant leptin (PEG-OB) prevents the decrease in cellular and humoral inflammation parameters during a very low calorie diet in healthy overweight young men. Except for B cells, PEG-OB treatment did not influence the decline in total leukocyte count and mononuclear subfractions during the diet. Weight loss decreased the humoral inflammation parameters TNFalpha, tissue plasminogen activator, and von Willebrand factor (P < 0.05), but in combination with PEG-OB treatment, a significant decrease was shown for inflammation markers as a whole (P < 0.014) and that of the individual parameters tissue plasminogen activator, von Willebrand factor, plasminogen activator inhibitor type 1, and intercellular adhesion molecule-1 (P < 0.05). The increase in C-reactive protein levels (P < 0.05) was the sole indication for a humoral proinflammatory action of leptin. Although PEG-OB treatment significantly increased weight loss (P < 0.03), the data do not support a proinflammatory role of leptin in human obesity.
Original languageEnglish
Pages (from-to)1773-1778
JournalJournal of Clinical Endocrinology & Metabolism
Volume89
Issue number4
DOIs
Publication statusPublished - 1 Jan 2004

Cite this